News - Page 41 - Psychedelic Alpha

Read more about the article COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference

COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference

Post published:May 27, 2023
Post category:Press Release

Read more about the article Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

Post published:May 26, 2023
Post category:Press Release

Read more about the article Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients with major depressive disorder (MDD)

Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients with major depressive disorder (MDD)

Post published:May 26, 2023
Post category:Press Release

Read more about the article Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023

Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023

Post published:May 26, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Significant Developments In Intellectual Property Portfolio

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

Post published:May 25, 2023
Post category:Press Release

Read more about the article Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

Post published:May 25, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

Post published:May 22, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Post published:May 19, 2023
Post category:Press Release

Read more about the article Terran Biosciences discovers what may be the first new salts, co-crystals, and polymorphs of psilocybin in history, publishes PCT patent application, and files psilocybin Drug Master File (DMF) with FDA

Terran Biosciences discovers what may be the first new salts, co-crystals, and polymorphs of psilocybin in history, publishes PCT patent application, and files psilocybin Drug Master File (DMF) with FDA

Post published:May 19, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES FIRST EVER NAGOYA PROTOCOL-COMPLIANT SHIPMENT OF IBOGA FROM GABON

FILAMENT HEALTH ANNOUNCES FIRST EVER NAGOYA PROTOCOL-COMPLIANT SHIPMENT OF IBOGA FROM GABON

Post published:May 17, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.